Join
Live feed
·
PRReleasevia Quantisnow
UnitedHealth Group Incorporated logo
Eli Lilly and Company logo

Lilly and UnitedHealth Group partner on pragmatic study of neutralizing antibody bamlanivimab (LY-CoV555) for COVID-19

ByQuantisnow·Wall Street's wire, on your screen.
UNH· UnitedHealth Group IncorporatedLLY· Eli Lilly and Company
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track UNH (UnitedHealth Group Incorporated), LLY (Eli Lilly and Company) and more on Quantisnow.

Lilly and UnitedHealth Group partner on pragmatic study of neutralizing antibody bamlanivimab (LY-CoV555) for COVID-19 | Quantisnow